Entity Details

Primary name NU2M_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP03891
EntryNameNU2M_HUMAN
FullNameNADH-ubiquinone oxidoreductase chain 2
TaxID9606
Evidenceevidence at protein level
Length347
SequenceStatuscomplete
DateCreated1986-07-21
DateModified2021-06-02

Ontological Relatives

GenesND2

GO terms

Show/Hide Table
GOName
GO:0005743 mitochondrial inner membrane
GO:0005747 mitochondrial respiratory chain complex I
GO:0006120 mitochondrial electron transport, NADH to ubiquinone
GO:0008137 NADH dehydrogenase (ubiquinone) activity
GO:0014069 postsynaptic density
GO:0016021 integral component of membrane
GO:0019901 protein kinase binding
GO:0032981 mitochondrial respiratory chain complex I assembly
GO:0035255 ionotropic glutamate receptor binding
GO:0072593 reactive oxygen species metabolic process

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion inner membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001750 NADH:quinone oxidoreductase/Mrp antiporter, membrane subunitDomainDomain
IPR003917 NADH:ubiquinone oxidoreductase, chain 2FamilyFamily
IPR010933 NADH dehydrogenase subunit 2, C-terminalDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
535000 OMIMLeber hereditary optic neuropathy (LHON)A maternally inherited disease resulting in acute or subacute loss of central vision, due to optic nerve dysfunction. Cardiac conduction defects and neurological defects have also been described in some patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes. The disease is caused by variants affecting the gene represented in this entry.
256000 OMIMLeigh syndrome (LS)An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. Disease susceptibility is associated with variants affecting the gene represented in this entry.
502500 OMIMAlzheimer disease mitochondrial (AD-MT)Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death. Disease susceptibility may be associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00157 NADHDrugbanksmall molecule

Interactions

4 interactions